Novartis to acquire Biopharma Company avidity biosciences for $12 bln

Azernews.Az

27 October 2025 20:11 (UTC+04:00)

Novartis AG announced that it has reached an agreement to acquire San Diego-based biopharmaceutical company Avidity Biosciences, Inc., for nearly $12 billion in cash, Azernews reports, citing foreign media.

Access to paid information is limited

Find the plan that suits you best.

1 month subscription

Full digital access to all news for 1 month

1.00₼

Select

3 months subscription

Full digital access to all news for 3 months

2.00₼

Select

-33%

6 months subscription

Full digital access to all news for 6 months

3.84₼

Select

-36%

1 year subscription

Full digital access to all news for 1 year

7.10₼

Select

-41%

Here we are to serve you with news right now. It does not cost much, but worth your attention.

Choose to support open, independent, quality journalism and subscribe on a monthly basis.

By subscribing to our online newspaper, you can have full digital access to all news, analysis, and much more.

You can also follow AzerNEWS on Twitter @AzerNewsAz or Facebook @AzerNewsNewspaper

Thank you!